Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Uptake Medical was a medical technology company dedicated to developing innovative, minimally invasive solutions for severe lung diseases, including emphysema and lung cancer. Their flagship technology, the InterVapor® System, utilized targeted steam vapor ablation for bronchoscopic treatments. Founded in 2005, the company made significant strides in interventional pulmonology, aiming to improve patient outcomes and quality of life. In June 2016, Uptake Medical's assets were acquired by Broncus Medical, Inc., which continues to advance and commercialize the vapor ablation technology as part of its broader portfolio of diagnostic and therapeutic solutions for lung conditions.
Served as the central hub for research and development, clinical trials, operations, and corporate administration for its innovative lung treatment technologies.
The facility likely included specialized R&D laboratories for medical device development, potentially cleanroom spaces for assembly or testing, and office areas for engineering, clinical, and administrative staff. Specific architectural details are not widely publicized.
As a company focused on cutting-edge medical innovation, the culture at Uptake Medical likely emphasized scientific rigor, collaboration between engineering and clinical teams, and a strong patient-centric approach to product development. Characteristics of a dynamic start-up environment, such as agility and a strong sense of mission, were probable.
The Tustin headquarters was significant as the primary development center for the InterVapor® technology, positioning Uptake Medical within Southern California's prominent medtech cluster and facilitating its research and commercialization efforts.
Before its acquisition by Broncus Medical, Uptake Medical was actively working to secure regulatory approvals and initiate the commercialization of its InterVapor® System in key international markets, notably the United States and Europe. Its global reach was extended through clinical trials and collaborations with medical institutions worldwide, aiming to establish its vapor ablation technology as a valuable treatment option for specific lung conditions.
1382 Valencia Ave, Ste H
Tustin
CA
USA
Address: 201 S. Jackson Street, Suite 300, Seattle, WA 98104
The Seattle location may have leveraged the city's biotechnology and medical research ecosystem for early-stage development, talent acquisition, and initial funding efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Uptake Medical' leadership includes:
Uptake Medical has been backed by several prominent investors over the years, including:
Uptake Medical's assets were acquired by Broncus Medical in June 2016. Consequently, there have been no executive hires or exits attributable to 'Uptake Medical' as an independent entity in the last 12 months. Any leadership changes concerning its technology would occur within Broncus Medical.
Discover the tools Uptake Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its 2016 acquisition, Uptake Medical, like many companies of its size in the medtech sector, likely used standard corporate email formats. The domain 'uptakemedical.com' is no longer active for email communications related to the original company.
Common historical formats likely included [first_initial][last]@uptakemedical.com (e.g., jdoe@uptakemedical.com) or [first].[last]@uptakemedical.com (e.g., jane.doe@uptakemedical.com).
Format
j.doe@uptakemedical.com (example historical format, domain inactive)
Example
N/A (Company acquired, domain inactive)%
Success rate
PR Newswire • June 9, 2016
Broncus Medical, Inc., a company developing and marketing diagnostic and therapeutic technologies for lung disease, announced its acquisition of the assets of Uptake Medical. Uptake Medical was known for its InterVapor® (BTVA®) therapy, a minimally invasive treatment for severe emphysema and potentially lung cancer....more
Business Wire • March 11, 2015
Uptake Medical announced it had received CE Mark approval for its InterVapor system to be used for the bronchoscopic thermal vapor ablation (BTVA) of tumors in the airways. This expanded the application of its targeted steam vapor technology from severe emphysema to include lung cancer treatment....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Uptake Medical, are just a search away.